1. Home
  2. GKOS vs AVAV Comparison

GKOS vs AVAV Comparison

Compare GKOS & AVAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$153.58

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Logo AeroVironment Inc.

AVAV

AeroVironment Inc.

HOLD

Current Price

$149.51

Market Cap

8.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
AVAV
Founded
1998
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.6B
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
GKOS
AVAV
Price
$153.58
$149.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
17
Target Price
$126.92
$316.88
AVG Volume (30 Days)
692.4K
2.1M
Earning Date
04-29-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.32
$135.55
Revenue Next Year
$27.43
$14.90
P/E Ratio
N/A
N/A
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$135.20
52 Week High
$161.53
$417.86

Technical Indicators

Market Signals
Indicator
GKOS
AVAV
Relative Strength Index (RSI) 61.97 46.76
Support Level $96.44 $137.15
Resistance Level $161.53 $220.08
Average True Range (ATR) 5.46 8.49
MACD -0.85 1.29
Stochastic Oscillator 55.40 29.54

Price Performance

Historical Comparison
GKOS
AVAV

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About AVAV AeroVironment Inc.

AeroVironment Inc supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Company operates in three segments: UxS, LMS, MW.

Share on Social Networks: